Women's Cancer Research Foundation
Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older
In a recent study, researchers sought to assess the association between use of bisphosphonates and the risk of epithelial ovarian cancer.
top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Search
bottom of page